Dr. Kim O’Sullivan

Lab head, Translational Kidney Therapies @MonashCID researching Vasculitis, NETs, & the microbiome in autoimmune kidney diseases.Big supporter of women in STEM.

[Dr. Kim O’Sullivan @Kim_M_OS]

Happy to share our latest review on my favourite form of cell death....@SCSMonash @MonashCID Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis? https://t.co/mJj7uJkJBu

[ANZ Vasculitis Society, '26 Vasculitis Wkshop host @anzvasc]

Great to be partnering with the excellence of the @VasculitisFound for the Community and Patient Conference at #vasculitismelbourne early next year!
Register here for any and all Workshop events: https://t.co/PMo7bFK34D

[ANZ Vasculitis Society, '26 Vasculitis Wkshop host @anzvasc]

Don't miss your chance to share new findings at the 22nd International Vasculitis Workshop! If you have been waiting to submit your late breaking abstract, consider this is your friendly reminder.

Deadline: Wednesday 10 December, 2025
Submit: https://t.co/1RSa61MG51

[Dr. Kim O’Sullivan @Kim_M_OS]

Fabulous collaboration between @SCSMonash @MonashCID @Hudson_Research and A/Prof Grant Logan from @CMRI_AUS harnessing gene therapy to deliver therapeutic doses of DNaseI to clear extracellular DNA release from NETs in experimental ANCA Vasculitis.

[JCI insight @JCI_insight]

Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis?

@Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis.

See full report: https://t.co/87eCohbpsH

[Kitching Laboratory @KitchingLab]

Time is critical in AAV: dampening kidney inflammation prevents damage
Why not target effector T cells - leave other T cells alone?
Our paper in @NDTSocial defines IL-7Ra as a target
https://t.co/EOLHWhFNH1
Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy

[Arkana Laboratories @arkanalabs]

Today's #eyeSCANdy is an acellular scanning EM of a glomerulus from a biopsy with membranous glomerulonephritis, stage II showing a reticular pattern of the subepithelial GBM.

Photo courtesy of Dr. Stephen Bonsib. #renal #pathology

[Dr. Kim O’Sullivan @Kim_M_OS]

@DrDanikaHill Congratulations Danika! That is amazing!

[Dr. Kim O’Sullivan @Kim_M_OS]

Great day out for the Bladder and Kidney Disease Symposium with @MHickey_IVM the Director of @MonashCID telling us how cells traffic through the glomerulus!

[Dr. Glaucomflecken @DGlaucomflecken]

I truly do not think anybody loves the organ they specialize in more than nephrologists love the kidney

[Supertanskiii @supertanskiii]

The horrifying reality of being a woman, perfectly summarised by @_CaitlinORyan

If you give even the slightest shit about women, watch it all. This is what it’s like.

[Malcolm Starkey 🏴󠁧󠁢󠁷󠁬󠁳󠁿🇦🇺🥋🥼 @malcolm_starkey]

Please RT: FREE registration to the 2024 #Bladder & #Kidney Health Symposium for graduate research students @MonashSTM @SCSMonash @MonashBDI @Monash_FMNHS @MonashCID @WestmeadInst @SABE_latrobe

[Mushtaq Bilal, PhD @MushtaqBilalPhD]

Major academic publishers' revenue and what they pay authors and reviewers:

Revenue:
Elsevier: $3.9 billion
Springer Nature: $2 billion
Wolters Kluwer: $1.6 billion
Wiley: $1.8 billion
Taylor & Francis: $800 million
Sage: $500 million

They pay:
Authors: $0
Reviewers: $0

[Dr. Kim O’Sullivan @Kim_M_OS]

@AndrewMallett8 @TownsvilleHHS Congratulations!!!! So well deserved 🎉🍾

[Dr. Kim O’Sullivan @Kim_M_OS]

@ajithvasanthan @nhmrc @ml_labat @belinda @WEHI_research @KalliesLab @TheDoherty @Emily_Pilk @MIPS_Australia @ONJCRI Congratulations superstar!

[Dr. Kim O’Sullivan @Kim_M_OS]

@Feargal_Ryan @sahmriAU Congratulations! Very exciting news 🎉🍾

[Dr. Kim O’Sullivan @Kim_M_OS]

Love this time of year where we get to share graduation day with our students and colleagues! Congratulations to my colleague of 12 years Dr Peter Eggenhuizen and my Master Student Farhana Amreen from @MonashCID @SCSMonash @Monash_FMNHS !!🎓🎉

[Dr. Kim O’Sullivan @Kim_M_OS]

Big shout out to @BioCurate for sponsoring @ImmuMon today held at @MonashCID @CiiiD_Hudson - event would not be possible without this support!

[Dr. Kim O’Sullivan @Kim_M_OS]

Our very win @ImmuMon committee member @ZhoujieDing from @MonashImmunol leading the first flash talk of the day!!!

[Dr. Kim O’Sullivan @Kim_M_OS]

Dr Andrew Bray from @Monash_FMNHS explaining the patent cliff in the autoimmune landscape and the importance in developing oral therapies opposed to injectables @ImmuMon

[Dr. Kim O’Sullivan @Kim_M_OS]

How do we commercialise our research? @DrSarahAJones from @MonashCID shares her story at @ImmuMon today